NASDAQ : APLT

Applied Therapeutics, Inc.

$0.103 USD

$0.0 (0.0%)

Volume
0
Average Volume
15.8M
Market Capitalization
$14.86M
P/E Ratio
-0.24
Dividend Yield
0.00%
Price Target
$2.13
Year High
$1.50
Year Low
$0.09
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.96
Company Overview

NASDAQ

Les D. Funtleyder

Biotechnology

Healthcare

APLT

35

US

USD

https://www.appliedtherapeutics.com

212 220 9226

03828A101

0001697532

Liquidity Metrics

-4.46

0.96

0.96

0.36

0.00

Sales & Valuation

$455K

14.86

-26.72

-0.22

-0.46

Profitability

-$0.76

-$105.62M

-6214.50%

-6214.50%

-348.18%

-180.79%

P/E Metrics

-0.24

0.00

0.00

Analyst Price Target & Rating

$2.13

$4.00

$0.25

N/A

0/5

11 Analysts

-95.15%

Financial Health Scores

-27.42

1/9

-$1.25M

$34.37M

$34.94M

-$18.14M

Key Metrics (TTM)

$5.42M

5.42

-0.09

0.96

-348.18%

-3371.89%

-414.50%

-453.33%

5980 days

Company Executives
Name Title
Todd F. Baumgartner Chief Regulatory Officer
Corwin Dale Hooks Chief Commercial Officer
Catherine Thorpe Interim Chief Accounting Officer
Dottie Caplan Executive Vice President of Patient Advocacy & Government Affairs.
Reena Thomas Colacot Head of Quality
Evan Prescott Bailey Chief Medical Officer
Constantine Chinoporos Chief Operating Officer & Chief Business Officer
Les D. Funtleyder Interm Chief Executive Officer, Chief Financial Officer, Principal Financial Officer & Director
Poll Results

No votes yet today — be the first to share your view!

About Applied Therapeutics, Inc. (NASDAQ:APLT) Stock

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is presently in a pediatric clinical study for the same indication in children. Additionally, AT-007 is being investigated for its potential to address sorbitol dehydrogenase deficiency and phosphomannomutase enzyme-CDG. Another key compound, AT-001, is currently undergoing pivotal Phase III clinical trials. This therapy is being evaluated for its efficacy in treating both diabetic cardiomyopathy and diabetic peripheral neuropathy. Beyond its clinical ... pipeline, the company also maintains an early-stage preclinical portfolio. This includes AT-003, which is being developed for diabetic retinopathy, and AT-104. AT-104 is a PI3K inhibitor specifically designed to target T-Cell Acute Lymphoblastic Leukemia, a rare form of blood cancer. Applied Therapeutics, Inc. was established in 2016 and operates from its headquarters in New York City.

Frequently Asked Questions

What is the current Applied Therapeutics, Inc. (APLT) stock price?

Applied Therapeutics, Inc.(NASDAQ:APLT) stock price is $0.103 in the last trading session. During the trading session, APLT stock reached the peak price of $1.5 while $0.09 was the lowest point it dropped to. The percentage change in APLT stock occurred in the recent session was 0.0% while the dollar amount for the price change in APLT stock was $0.0.

APLT's industry and sector of operation?

The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of APLT?

Todd F. Baumgartner | Chief Regulatory Officer
Corwin Dale Hooks | Chief Commercial Officer
Catherine Thorpe | Interim Chief Accounting Officer
Dottie Caplan | Executive Vice President of Patient Advocacy & Government Affairs.
Reena Thomas Colacot | Head of Quality

How many employees does APLT have?

Number of APLT employees currently stands at 35. APLT operates from 545 Fifth Avenue, New York City, NY 10017, US.

Link for APLT official website?

Official Website of APLT is: https://www.appliedtherapeutics.com

How do I contact APLT?

APLT could be contacted at phone #212 220 9226 and can also be accessed through its website. APLT operates from 545 Fifth Avenue, New York City, NY 10017, US.

How many shares of APLT are traded daily?

The average number of APLT shares traded daily for last 3 months was 15.8M.

What is the market cap of APLT currently?

The market value of APLT currently stands at $14.86M with its latest stock price at $0.103